Latest Articles

Publication Date
Risk factors for uterine adenomyosis diagnosed by MRI in women of reproductive age.

Adenomyosis is a condition characterized by the presence of endometrial glands and stroma within the myometrium. It can manifest as either focal or diffuse. While histopathological examination of the uterus …

Published: March 9, 2025, midnight
Mehwish Hayat performs Umrah, shares video from Makkah - MSN

Mehwish Hayat performs Umrah, shares video from Makkah MSN

Published: March 1, 2025, 7:20 p.m.
Dual targeting of CXCR4 and EZH2 in endometriosis.

We recently showed that endometriotic peritoneal fluid (PF) altered the regulation of enhancer of zeste homolog 2 (EZH2) and H3K27me3. This study aimed to determine if PF by regulating EZH2/H3K27me3 …

Published: March 1, 2025, midnight
Patterns of associations with epidemiologic factors by high grade serous ovarian cancer gene expression subtypes.

Ovarian high-grade serous carcinomas (HGSC) comprise four distinct molecular subtypes based on mRNA expression patterns, with differential survival. Understanding risk factor associations is important to elucidate the etiology of HGSC. …

Published: Feb. 26, 2025, midnight
Causal Effect Between Natural Hair Color and Endometriosis in a European Population: A Two-Sample Mendelian Randomization.

Previous observational studies have suggested an association between natural hair color and the risk of endometriosis; however, the causal relationship remains unclear. Here, we conducted a two-sample Mendelian randomization (MR) …

Published: Feb. 25, 2025, midnight
Primary Low-Grade Endometrial Stromal Sarcoma of the Ovary Arising From Endometriosis: A Case Report.

Low-grade endometrial stromal sarcoma (LGESS) is a rare mesenchymal tumor of female genital tract malignancies. While it primarily arises in the uterus, extrauterine cases, including those originating in the ovary, …

Published: Feb. 23, 2025, midnight
Ananda Pharma's MRX1 moves closer to clinical trials - ICYMI - Proactive Investors UK

Ananda Pharma's MRX1 moves closer to clinical trials - ICYMI Proactive Investors UK

Published: Feb. 22, 2025, 5:05 a.m.
Prioritization of potential drug targets in ovarian-related diseases: Mendelian randomization and colocalization analyses.

To identify key genes and potential drug targets for ovarian-related diseases through genome-wide Mendelian randomization (MR) and colocalization analyses.

Published: Feb. 21, 2025, midnight
Ananda Pharma's MRX1 moves closer to clinical trials after key milestone - Proactive Investors UK

Ananda Pharma's MRX1 moves closer to clinical trials after key milestone Proactive Investors UK

Published: Feb. 20, 2025, 3:20 p.m.
IGF2BP1 promotes endometriosis by enhancing m6A modification stability of HMGB1.

Endometriosis is a chronic inflammatory condition afflicting women of reproductive age. Our study aims to clarify the function and mechanism of insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) and …

Published: Feb. 20, 2025, 12:06 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!